The Gemcitabine HCL market Size is a critical segment within the oncology pharmaceutical industry, focusing on the production and distribution of gemcitabine hydrochloride, a chemotherapy agent used to treat various cancers, including breast, ovarian, non-small cell lung, pancreatic, and bladder cancers. In 2023, the market was valued at approximately USD 497.83 million and is...